Vsmall
Vsmall is vildagliptin 50mg tablets for type 2 diabetes mellitus, a DPP-4 inhibitor that raises the level of incretin hormones.
- Category
- Diabetes Management
- Active ingredient
- Vildagliptin
- Route
- Oral use
- Form
- Tablet
- Strengths
- 50mg
No prescription needed: we place your order for Vsmall on your behalf.
Vsmall details
- Condition
- Type 2 Diabetes Mellitus
- Alternative names
- Galvus
- Therapeutic class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
- Pharmacological class
- Gliptin
- Contraindications
- hypersensitivity to vildagliptin; severe hepatic impairment
- Precautions and warnings
- monitor liver function tests; watch for symptoms of pancreatitis
- Minor side effects
- dizziness; headache
- Moderate side effects
- tremor; nausea; upper respiratory tract infection
- Dosage forms
- Tablet
- Administration route
- Oral use
- Manufacturer
- Novartis
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 30°C in a dry place.
- Drug interactions
- thiazides; corticosteroids
- Age restrictions
- Not recommended for children.
- Pregnancy and breastfeeding
- Pregnancy: Generally not recommended. Breastfeeding: Not recommended.
Serious side effects
pancreatitis, requires immediate medical attention; hepatitis, requires immediate medical attention
Patient summary
Vsmall is vildagliptin 50mg tablets for type 2 diabetes mellitus, a DPP-4 inhibitor that raises the level of incretin hormones.
Mechanism of action
Vildagliptin is a DPP-4 inhibitor. It works by increasing the levels of incretin hormones in the body, which helps stimulate insulin secretion and suppress glucagon release in a glucose-dependent manner, thereby stabilizing blood sugar levels.
About Vsmall
Vsmall is a brand of vildagliptin, a medication used in the management of type 2 diabetes mellitus. The same active ingredient is also sold under the brand name Galvus, supplied as a tablet in 50mg strength. This medication is designed to aid in blood sugar control for adults.